Search results
AIMS AND SCOPE. The aim of this document is to offer evidence-based rec-ommendations and clinical guidelines addressing key issues related to screening and surveillance in patients with BE.
Proton pump inhibitors (PPIs) have the best clinical profile for symptomatic management (Recommendation grade A). Antireflux surgery is not superior to pharmacological acid suppression for the prevention of neoplastic progression of Barrett's oesophagus (Recommendation grade C).
1. How should Barrett’s oesophagus be defined and which patients should undergo regular surveillance? 2. Are there clinical features associated with increased cancer risk in Barrett’s oesophagus, which should influence the frequency of endo-scopic surveillance? 3. Are there diagnostic tools that should be uti-lised to screen the ...
8 lut 2023 · This guideline covers monitoring, treatment and follow-up for people aged 18 and over with Barrett’s oesophagus and stage 1 oesophageal adenocarcinoma. It includes advice on endoscopic and non-endoscopic techniques.
treated by endoscopic resection, provided that adequate follow-up with gastroscopy, endoscopic ultrasound (EUS), and computed tomography (CT)/positrion emission tomo-graphy-computed tomography (PET-CT) is performed in expertcenters. Weak recommendation, low quality of evidence. MR9 ESGE suggests that submucosal (T1b) esophageal
Abstract. Barrett’s esophagus (BE) is among the most common conditions encountered by the gastroenterologist. In this document, the American College of Gastroenterology updates its guidance for the best practices in caring for these patients.
Surveillance in BE is aimed at early detection of dysplasia. Dysplasia is categorized as NDBE, indeterminate, LGD, HGD, or carcinoma [56]. The presence of dysplasia should be confirmed by a second pathologist expert in GI histopathology, due to a high degree of inter-observer variability [56].
